164 related articles for article (PubMed ID: 33452446)
1. CD79a promotes CNS-infiltration and leukemia engraftment in pediatric B-cell precursor acute lymphoblastic leukemia.
Lenk L; Carlet M; Vogiatzi F; Spory L; Winterberg D; Cousins A; Vossen-Gajcy M; Ibruli O; Vokuhl C; Cario G; El Ayoubi O; Kramer L; Ritgen M; Brüggemann M; Häsler R; Schrappe M; Fuhrmann S; Halsey C; Jeremias I; Hobeika E; Jumaa H; Alsadeq A; Schewe DM
Commun Biol; 2021 Jan; 4(1):73. PubMed ID: 33452446
[TBL] [Abstract][Full Text] [Related]
2. Hypoxic adaptation of leukemic cells infiltrating the CNS affords a therapeutic strategy targeting VEGFA.
Kato I; Nishinaka Y; Nakamura M; Akarca AU; Niwa A; Ozawa H; Yoshida K; Mori M; Wang D; Morita M; Ueno H; Shiozawa Y; Shiraishi Y; Miyano S; Gupta R; Umeda K; Watanabe K; Koh K; Adachi S; Heike T; Saito MK; Sanada M; Ogawa S; Marafioti T; Watanabe A; Nakahata T; Enver T
Blood; 2017 Jun; 129(23):3126-3129. PubMed ID: 28424164
[No Abstract] [Full Text] [Related]
3. IL7R is associated with CNS infiltration and relapse in pediatric B-cell precursor acute lymphoblastic leukemia.
Alsadeq A; Lenk L; Vadakumchery A; Cousins A; Vokuhl C; Khadour A; Vogiatzi F; Seyfried F; Meyer LH; Cario G; Hobeika E; Debatin KM; Halsey C; Schrappe M; Schewe DM; Jumaa H
Blood; 2018 Oct; 132(15):1614-1617. PubMed ID: 30154115
[No Abstract] [Full Text] [Related]
4. Identification and characterization of a murine model of BCR‑ABL1+ acute B‑lymphoblastic leukemia with central nervous system metastasis.
Yu X; Zhang H; Yuan M; Zhang P; Wang Y; Zheng M; Lv Z; Odhiambo WO; Li C; Liu C; Ma Y; Ji Y
Oncol Rep; 2019 Aug; 42(2):521-532. PubMed ID: 31173268
[TBL] [Abstract][Full Text] [Related]
5. Role of CXCR4-mediated bone marrow colonization in CNS infiltration by T cell acute lymphoblastic leukemia.
Jost TR; Borga C; Radaelli E; Romagnani A; Perruzza L; Omodho L; Cazzaniga G; Biondi A; Indraccolo S; Thelen M; Te Kronnie G; Grassi F
J Leukoc Biol; 2016 Jun; 99(6):1077-87. PubMed ID: 26931577
[TBL] [Abstract][Full Text] [Related]
6. Central nervous system involvement in acute lymphoblastic leukemia is mediated by vascular endothelial growth factor.
Münch V; Trentin L; Herzig J; Demir S; Seyfried F; Kraus JM; Kestler HA; Köhler R; Barth TFE; Te Kronnie G; Debatin KM; Meyer LH
Blood; 2017 Aug; 130(5):643-654. PubMed ID: 28550041
[TBL] [Abstract][Full Text] [Related]
7. PRMT5-mediated H4R3sme2 Confers Cell Differentiation in Pediatric B-cell Precursor Acute Lymphoblastic Leukemia.
Mei M; Zhang R; Zhou ZW; Ying Z; Wang J; Zhang H; Zheng H; Bao S
Clin Cancer Res; 2019 Apr; 25(8):2633-2643. PubMed ID: 30635341
[TBL] [Abstract][Full Text] [Related]
8. Wntless (GPR177) expression correlates with poor prognosis in B-cell precursor acute lymphoblastic leukemia via Wnt signaling.
Chiou SS; Wang LT; Huang SB; Chai CY; Wang SN; Liao YM; Lin PC; Liu KY; Hsu SH
Carcinogenesis; 2014 Oct; 35(10):2357-64. PubMed ID: 25115440
[TBL] [Abstract][Full Text] [Related]
9. New cellular markers at diagnosis are associated with isolated central nervous system relapse in paediatric B-cell precursor acute lymphoblastic leukaemia.
van der Velden VH; de Launaij D; de Vries JF; de Haas V; Sonneveld E; Voerman JS; de Bie M; Revesz T; Avigad S; Yeoh AE; Swagemakers SM; Eckert C; Pieters R; van Dongen JJ
Br J Haematol; 2016 Mar; 172(5):769-81. PubMed ID: 26898195
[TBL] [Abstract][Full Text] [Related]
10. The role of ZAP70 kinase in acute lymphoblastic leukemia infiltration into the central nervous system.
Alsadeq A; Fedders H; Vokuhl C; Belau NM; Zimmermann M; Wirbelauer T; Spielberg S; Vossen-Gajcy M; Cario G; Schrappe M; Schewe DM
Haematologica; 2017 Feb; 102(2):346-355. PubMed ID: 27686375
[TBL] [Abstract][Full Text] [Related]
11. High BMP4 expression in low/intermediate risk BCP-ALL identifies children with poor outcomes.
Fernández-Sevilla LM; Valencia J; Ortiz-Sánchez P; Fraile-Ramos A; Zuluaga P; Jiménez E; Sacedón R; Martínez-Sánchez MV; Jazbec J; Debeljak M; Fedders B; Stanulla M; Schewe D; Cario G; Minguela A; Ramírez M; Varas A; Vicente Á
Blood; 2022 Jun; 139(22):3303-3313. PubMed ID: 35313334
[TBL] [Abstract][Full Text] [Related]
12. CD43, but not P-selectin glycoprotein ligand-1, functions as an E-selectin counter-receptor in human pre-B-cell leukemia NALL-1.
Nonomura C; Kikuchi J; Kiyokawa N; Ozaki H; Mitsunaga K; Ando H; Kanamori A; Kannagi R; Fujimoto J; Muroi K; Furukawa Y; Nakamura M
Cancer Res; 2008 Feb; 68(3):790-9. PubMed ID: 18245480
[TBL] [Abstract][Full Text] [Related]
13. The ability to cross the blood-cerebrospinal fluid barrier is a generic property of acute lymphoblastic leukemia blasts.
Williams MT; Yousafzai YM; Elder A; Rehe K; Bomken S; Frishman-Levy L; Tavor S; Sinclair P; Dormon K; Masic D; Perry T; Weston VJ; Kearns P; Blair H; Russell LJ; Heidenreich O; Irving JA; Izraeli S; Vormoor J; Graham GJ; Halsey C
Blood; 2016 Apr; 127(16):1998-2006. PubMed ID: 26869395
[TBL] [Abstract][Full Text] [Related]
14. Targeted blockade of immune mechanisms inhibit B precursor acute lymphoblastic leukemia cell invasion of the central nervous system.
Rajakumar SA; Grandal I; Minden MD; Hitzler JK; Guidos CJ; Danska JS
Cell Rep Med; 2021 Dec; 2(12):100470. PubMed ID: 35028611
[TBL] [Abstract][Full Text] [Related]
15. CD79: a review.
Chu PG; Arber DA
Appl Immunohistochem Mol Morphol; 2001 Jun; 9(2):97-106. PubMed ID: 11396639
[TBL] [Abstract][Full Text] [Related]
16. Puppet masters of B-cell progenitor acute lymphoblastic leukemia: The preB cell receptor and the interleukin 7 receptor α.
Das Gupta D; Lohoff M
Eur J Immunol; 2023 Apr; 53(4):e2250093. PubMed ID: 36805963
[TBL] [Abstract][Full Text] [Related]
17. Targeted therapy with MXD3 siRNA, anti-CD22 antibody and nanoparticles for precursor B-cell acute lymphoblastic leukaemia.
Satake N; Duong C; Chen C; Barisone GA; Diaz E; Tuscano J; Rocke DM; Nolta J; Nitin N
Br J Haematol; 2014 Nov; 167(4):487-99. PubMed ID: 25196579
[TBL] [Abstract][Full Text] [Related]
18. Molecular and phenotypic characterization of an early T-cell precursor acute lymphoblastic lymphoma harboring PICALM-MLLT10 fusion with aberrant expression of B-cell antigens.
Khurana S; Melody ME; Ketterling RP; Peterson JF; Luoma IM; Vazmatzis G; Tun HW; Foran JM; Jiang L
Cancer Genet; 2020 Jan; 240():40-44. PubMed ID: 31739126
[TBL] [Abstract][Full Text] [Related]
19. Eradication of Central Nervous System Leukemia of T-Cell Origin with a Brain-Permeable LSD1 Inhibitor.
Saito S; Kikuchi J; Koyama D; Sato S; Koyama H; Osada N; Kuroda Y; Akahane K; Inukai T; Umehara T; Furukawa Y
Clin Cancer Res; 2019 Mar; 25(5):1601-1611. PubMed ID: 30518632
[TBL] [Abstract][Full Text] [Related]
20. Identification of an altered immunoglobulin heavy-chain gene rearrangement in the central nervous system in B-precursor acute lymphoblastic leukemia.
Wasserman R; Felix CA; McKenzie SE; Shane S; Lange B; Finger LR
Leukemia; 1993 Aug; 7(8):1294-9. PubMed ID: 8350631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
